Intuitive Surgical, Inc. $ISRG Shares Sold by Choreo LLC

Choreo LLC trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 8,009 shares of the medical equipment provider’s stock after selling 2,426 shares during the period. Choreo LLC’s holdings in Intuitive Surgical were worth $3,257,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $14,316,000. Plato Investment Management Ltd purchased a new stake in Intuitive Surgical in the 2nd quarter worth approximately $4,315,000. Hikari Power Ltd purchased a new position in Intuitive Surgical in the second quarter valued at $5,619,000. NewEdge Advisors LLC increased its stake in shares of Intuitive Surgical by 19.1% in the 2nd quarter. NewEdge Advisors LLC now owns 50,825 shares of the medical equipment provider’s stock valued at $20,212,000 after purchasing an additional 8,142 shares in the last quarter. Finally, Nykredit A S acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $48,464,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $432.01 on Friday. The firm’s 50 day moving average price is $401.54 and its 200-day moving average price is $434.05. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The firm has a market cap of $149.75 billion, a P/E ratio of 52.24, a P/E/G ratio of 2.98 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the company posted $2.40 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 20,095 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the sale, the director owned 1,204,530 shares in the company, valued at $543,977,793.30. This trade represents a 1.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 38,778 shares of company stock valued at $16,814,967. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ISRG shares. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Wednesday, October 21st. Stifel Nicolaus reduced their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective on the stock. in a research note on Thursday, July 30th. Citigroup cut their target price on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a research note on Friday, July 17th. Finally, TD Cowen reiterated a “buy” rating and set a $485.00 price target on shares of Intuitive Surgical in a report on Monday, October 19th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.